IP Library Granted Patent US 6,947,844
Granted Patent B2
US 6,947,844 · App. 09/922,251 · Granted Sep 20, 2005

Modulators of ribosomal function and identification thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,947,844
App. No.
09/922,251
Granted
Sep 20, 2005
Kind
B2
Abstract

The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.

Claims (4)

1. A method of identifying a molecule that binds to a large ribosomal subunit, the method comprising the steps of:

(a) providing a molecular model comprising one or more target regions selected from the group consisting of the peptidyl transferase site, the A-site, the P-site, the E-site, the elongation factor binding domain, the polypeptide exit tunnel, and the signal recognition particle (SRP) binding domain, from the atomic co-ordinates for Haloarcula marismortui large ribosomal subunit found on Disk 1 under file names 1ffk.doc or 1ffk.ent or on Disk 2 under file names 1jj2rtf or 1jj2.txt, or a large ribosomal subunit derived from said Haloarcula marismortui atomic co-ordinates by molecular modeling;

(b) using the molecular model to identify a candidate molecule that can bind to said one or more target regions in the molecular model; and

(c) producing the candidate molecule identified in step (b).

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
SECURITY INTEREST Recorded Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
CHANGE OF NAME Recorded Oct 17, 2013
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031432/0123 →
CONFIRMATORY LICENSE Recorded Jun 1, 2010
From: YALE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024456/0742 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2005
From: BAN, NENAD
To: YALE UNIVERSITY
Reel/Frame 016307/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2001
From: STEITZ, THOMAS A., FOR MYSELF AND AS AN AGENT FOR HOWARD HUGHES MEDICAL INSTITUTE
To: YALE UNIVERSITY
Reel/Frame 012338/0849 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2001
From: STEITZ, THOMAS A.; MOORE, PETER B.; NISSEN, POUL; HANSEN, JEFFREY
To: YALE UNIVERSITY
Reel/Frame 012328/0635 →